维普中文期刊产品整合服务
12篇 您的检索式:作者名="Breazna"
    题名 作者 年代 出处 被引量
1Comparison of Effectiveness of Atorvastatin 10 mg Versus 80 mg in Reducing Major Cardiovascular Events and Repeat Revascularization in Patients With Previous Percutaneous Coronary Intervention (Post Hoc Analysis of the Treating to New Targets [TNT] Study)显示文摘Colleen Johnson David D. Waters David A. DeMicco Andrei Breazna Vera Bittner Heiner Greten Scott M. Grundy John C. LaRosa 2008The American Journal of Cardiology2008,,10:1
2Usefulness of Heart Rate at Rest as a Predictor of Mortality, Hospitalization for Heart Failure, Myocardial Infarction, and Stroke in Patients With Stable Coronary Heart Disease (Data from the Treating to New Targets [TNT] Trial)显示文摘Jennifer E. Ho Vera Bittner David A. DeMicco Andrei Breazna Prakash C. Deedwania David D. Waters 2010The American Journal of Cardiology2010,,7:1
3Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease显示文摘James Shepherd John J.P. Kastelein Vera Bittner Prakash Deedwania Andrei Breazna Stephen Dobson Daniel J. Wilson Andrea Zuckerman Nanette K. Wenger 2008Journal of the American College of Cardiology2008,,15:1
4Effect of atorv- astatin in elderly patients with a recent stroke or transient ischemic attack 显示文摘Chaturvedi S Zivin J Breazna A 2009Neurology2009,72,8:1
5Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy: The Treating to New Targets (TNT) Study显示文摘Samia Mora Nanette K. Wenger David A. DeMicco Andrei Breazna S. Matthijs Boekholdt Benoit J. Arsenault Prakash Deedwania John J.P. Kastelein David D. Waters 2012Circulation2012,,16:1
6Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease显示文摘James Shepherd John J.P. Kastelein Vera Bittner Prakash Deedwania Andrei Breazna Stephen Dobson Daniel J. Wilson Andrea Zuckerman Nanette K. Wenger 2008Journal of the American College of Cardiology2008,,15:1
7Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe显示文摘H. H. Feldman R. S. Doody M. Kivipelto D. L. Sparks D. D. Waters R. W. Jones E. Schwam R. Schindler J. Hey-Hadavi D. A. DeMicco A. Breazna 2010Neurology2010,,12:1
8Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT Trial显示文摘Bangalore S Breazna A DeMieco DA 2015J Am Coll Cardiol2015,65,15:1
9Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease显示文摘James Shepherd John J.P. Kastelein Vera Bittner Prakash Deedwania Andrei Breazna Stephen Dobson Daniel J. Wilson Andrea Zuckerman Nanette K. Wenger 2008Journal of the American College of Cardiology2008,,15:1
10Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A1c in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial显示文摘Philip J. Barter Kerry-Anne Rye Jean-Claude Tardif David D. Waters S. Matthijs Boekholdt Andrei Breazna John J.P. Kastelein 2011Circulation2011,,5:1
11Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack 显示文摘CHATURVEDI S ZIVIN J BREAZNA A 2009Neurology2009,72,:1
12Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin显示文摘David D. Waters Jennifer E. Ho David A. DeMicco Andrei Breazna Benoit J. Arsenault Chuan-Chuan Wun John J. Kastelein Helen Colhoun Philip Barter 2011Journal of the American College of Cardiology2011,,14:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费